Patient-reported outcomes with the β3-adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder

  1. Khullar, V.
  2. Amarenco, G.
  3. Angulo, J.C.
  4. Blauwet, M.B.
  5. Nazir, J.
  6. Odeyemi, I.A.
  7. Hakimi, Z.
Aldizkaria:
Neurourology and Urodynamics

ISSN: 1520-6777,  0733-2467

Argitalpen urtea: 2016

Alea: 35

Zenbakia: 8

Orrialdeak: 987-994

Mota: Artikulua

DOI: 10.1002/NAU.22844 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus